FindTrial
Sign In

Contrast-free cardiovascular magnetic resonance black-blood thrombus imaging for the precise diagnosis and prognosis of deep vein thrombosis

Contrast-free cardiovascular magnetic resonance black-blood thrombus imaging for the precise diagnosis and prognosis of deep vein thrombosis

Status
Recruiting
Phases
Early Phase 1
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR1900024809
Enrollment
Unknown
Registered
2019-07-28
Start date
2019-08-01
Completion date
Unknown
Last updated
2019-07-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

lower extremities deep venous thrombosis

Interventions

Gold Standard:Digital substraction angiography
Index test:Magnetic&#32
resonance&#32
Black&#32
Blood&#32
Thrombosis&#32
Imaging&#32
technique

Sponsors

Fujian Provincial Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1. Patients aged 18 years and older; 2. Patients underwent ultrasound exam with suspicious DVT; 3. Patients were capable of providing consent.

Exclusion criteria

Exclusion criteria: 1. History of May-Thurner syndrome (MTS) and post thrombosis syndrome (PTS); 2. History of iodine agent allergy; 3. Pregnant or lactating women; 4. Patients with claustrophobia. 5. Enrolled in another trial.

Design outcomes

Primary

MeasureTime frame
sensitivity;specificity;Youden index;positive likelihood ratio;negative likelihood ratio;positive predictive value;negative predictive value;—

Countries

China

Contacts

Public ContactZhangbo Cheng

Fujian Provincial Hospital

16016331@qq.com+86 18705050526

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026